Achieve Life Sciences Inc ACHV.O :
* ACHIEVE REPORTS FINANCIAL RESULTS FOR THIRD QUARTER 2019 AND PROVIDES UPDATE ON CYTISINICLINE DEVELOPMENT PROGRAM
* ACHIEVE LIFE SCIENCES INC - QTRLY DILUTED NET LOSS PER SHARE $0.45
Achieve Life Sciences Inc ACHV.O :
* ACHIEVE REPORTS FINANCIAL RESULTS FOR THIRD QUARTER 2019 AND PROVIDES UPDATE ON CYTISINICLINE DEVELOPMENT PROGRAM
* ACHIEVE LIFE SCIENCES INC - QTRLY DILUTED NET LOSS PER SHARE $0.45